Mefentrifluconazole
Mefentrifluconazole is a novel, orally bioavailable azole antifungal that potently and selectively inhibits fungal CYP51 (Kd=0.5 nM) with significantly lower activity against human aromatase (IC50=0.92 μM) . It serves as a valuable research tool for studying fungal sterol biosynthesis and has demonstrated broad-spectrum efficacy in both in vitro assays and in vivo plant protection models.
Product Specifications
CAS Number
1417782-03-6
Product Name Alternative
Cell, derivative, Cytochrome P450, CYPs, CYP51A, azole, aromatase, antifungal, necrosis, irritant, liver, inhibit, hypertrophy, Fungal, Mefentrifluconazole, Inhibitor
Field of Research
Infectious Disease & Virology, Metabolism Research
Purity
99.45% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (12.57 mM) ; DMSO:100 mg/mL (251.4 mM)
Smiles
CC (O) (Cn1cncn1) c1ccc (Oc2ccc (Cl) cc2) cc1C (F) (F) F
Molecular Formula
C18H15ClF3N3O2
Molecular Weight
397.78
Storage Conditions
-20°C
Notes
For research use only.